Invigor Medical review
Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog.
- Semaglutide
- $199/mo
- Tirzepatide
- $339/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
Semaglutide · modeled / year
$2,388
Tirzepatide · modeled / year
$4,068
The Index scorecard
Invigor Medical scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Competitive mid-market pricing on both semaglutide and tirzepatide
- Long-running operator with a broad catalog that can consolidate spend
- Both molecules published up front for easy cost modeling
The tradeoffs
- Does not publish an explicit states-served list, so access is a variable in the model
- Compounded only
The bottom line
Best for: Value shoppers who want competitive pricing on both molecules plus a wider wellness/hormone program on one account. Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog.
Ranked #2 of 9 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 8 other providers we've modeled, in Cost-Efficiency Index order.
- #1CoreAge Rx— Best value on the board: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser.94/100
- #3ShedRx— The lowest published tirzepatide cost among our partners, plus an oral/sublingual route — strong cost-per-month for the needle-averse.87/100
- #4Eden— You pay a premium per month, but you buy back certainty: all-50 access and high-disclosure clinical oversight that hold their value.86/100
- #5AgelessRx— The lowest published semaglutide cost on the board, with some brand-name access — but an undisclosed tirzepatide price leaves a hole in the value model.85/100
- #6Found— The cheapest identical price on both molecules nationwide — unbeatable raw cost-per-month, capped only by a coaching subscription you can't fully unbundle.88/100
- #7Ro— The widest formulary — brand-name and oral access — but opaque compounded pricing means you can't model the value until you're already in the funnel.84/100
- #8Hims & Hers— Nationwide reach and a slick app at a mid-market semaglutide price — but an undisclosed tirzepatide price leaves part of the value equation blank.83/100
- #9Henry Meds— A transparent flat-fee pioneer — the pricing is clean and modelable, but it now sits at the higher end, so the value per dollar has slipped.81/100
Pricing, states and verification reflect Invigor Medical's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Invigor Medical's site. Not medical advice; see our disclosure.